Overall, PTHrP serves as both a mediator of physiological calcium homeostasis and a pathological driver of breast cancer progression and bone metastatic colonization, highlighting its potential as a therapeutic target in metastatic breast cancer. Here, PTHLH is linked to breast cancer.